{"status":"OK","data":{"id":3044622,"identifier":"DVN/YHUB8D","persistentUrl":"https://doi.org/10.7910/DVN/YHUB8D","protocol":"doi","authority":"10.7910","publisher":"Harvard Dataverse","publicationDate":"2018-05-15","storageIdentifier":"s3://10.7910/DVN/YHUB8D","latestVersion":{"id":128158,"storageIdentifier":"s3://10.7910/DVN/YHUB8D","versionNumber":1,"versionMinorNumber":0,"versionState":"RELEASED","productionDate":"Production Date","lastUpdateTime":"2018-05-16T02:38:39Z","releaseTime":"2018-05-16T02:38:39Z","createTime":"2017-08-15T19:55:19Z","license":"CC0","termsOfUse":"CC0 Waiver","metadataBlocks":{"citation":{"displayName":"Citation Metadata","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"263_H15RC"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Choules, Mary"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"University of Illinois at Chicago"},"authorIdentifierScheme":{"typeName":"authorIdentifierScheme","multiple":false,"typeClass":"controlledVocabulary","value":"ORCID"},"authorIdentifier":{"typeName":"authorIdentifier","multiple":false,"typeClass":"primitive","value":"orcid.org/0000-0003-1771-3245"}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Choules, Mary"},"datasetContactAffiliation":{"typeName":"datasetContactAffiliation","multiple":false,"typeClass":"primitive","value":"University of Illinois at Chicago"},"datasetContactEmail":{"typeName":"datasetContactEmail","multiple":false,"typeClass":"primitive","value":"choules2@uic.edu"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"Raw NMR data for rufomyazine (1D and 2D), synthetic rufomyazine, and synthetic intermediate Fmoc-L-N-Me-Leu-N-(1,1-dimethyl-1-allyl)-L-Trp-OMe. Simulated PMS files with associated .mms structure files for rufomyazine"},"dsDescriptionDate":{"typeName":"dsDescriptionDate","multiple":false,"typeClass":"primitive","value":"2018-05-07"}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Chemistry"]},{"typeName":"publication","multiple":true,"typeClass":"compound","value":[{"publicationCitation":{"typeName":"publicationCitation","multiple":false,"typeClass":"primitive","value":"Residual Complexity Does Impact Organic Chemistry and Drug Discovery - The Case of Rufomyazine and Rufomycin"}}]},{"typeName":"language","multiple":true,"typeClass":"controlledVocabulary","value":["English"]},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"Choules, Mary"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2017-08-15"}]}},"files":[{"description":"Raw NMR data (400 MHz) of 4.13 mg Fmoc-L-N-Me-Leu-N-(1,1-dimethyl-1-allyl)-L-Trp-OMe and 0.85 mg DMBA (IC) in CD3OD. \r\nFiles contained: 1H, 13C, COSY, HSQC, HMBC","label":"Fmoc-L-N-Me-Leu-N-(1,1-dimethyl-1-allyl)-L-Trp-OMe(compound4).zip","restricted":false,"version":2,"datasetVersionId":128158,"dataFile":{"id":3151174,"persistentId":"doi:10.7910/DVN/YHUB8D/BWU6VV","pidURL":"https://doi.org/10.7910/DVN/YHUB8D/BWU6VV","filename":"Fmoc-L-N-Me-Leu-N-(1,1-dimethyl-1-allyl)-L-Trp-OMe(compound4).zip","contentType":"application/zip","filesize":22205199,"description":"Raw NMR data (400 MHz) of 4.13 mg Fmoc-L-N-Me-Leu-N-(1,1-dimethyl-1-allyl)-L-Trp-OMe and 0.85 mg DMBA (IC) in CD3OD. \r\nFiles contained: 1H, 13C, COSY, HSQC, HMBC","storageIdentifier":"s3://dvn-cloud:1633c6969cd-a7d97cbc9f41","rootDataFileId":-1,"md5":"7bdf24d585c573bb48ca80f663c3e79d","checksum":{"type":"MD5","value":"7bdf24d585c573bb48ca80f663c3e79d"}}},{"description":"qNMR spreadsheet files for rufomyazine (6), rufomycin (7), and Fmoc-L-N-Me-Leu-N-(1,1-dimethyl-1-allyl)-L-Trp-OMe (4)","label":"qNMR_analysis.zip","restricted":false,"version":1,"datasetVersionId":128158,"dataFile":{"id":3151175,"persistentId":"doi:10.7910/DVN/YHUB8D/OWX0CQ","pidURL":"https://doi.org/10.7910/DVN/YHUB8D/OWX0CQ","filename":"qNMR_analysis.zip","contentType":"application/zip","filesize":635185,"description":"qNMR spreadsheet files for rufomyazine (6), rufomycin (7), and Fmoc-L-N-Me-Leu-N-(1,1-dimethyl-1-allyl)-L-Trp-OMe (4)","storageIdentifier":"s3://dvn-cloud:1633c72f985-1446856adad5","rootDataFileId":-1,"md5":"a1403d81ee368db8ba2db25a4bec6c85","checksum":{"type":"MD5","value":"a1403d81ee368db8ba2db25a4bec6c85"}}},{"description":"Rufomycin calibration curve to determine the level of contamination in the biological assay sample of rufomyazine that was recovered","label":"RUF_calibrationcurve_final.ods","restricted":false,"version":1,"datasetVersionId":128158,"dataFile":{"id":3048502,"persistentId":"doi:10.7910/DVN/YHUB8D/ZXCCRM","pidURL":"https://doi.org/10.7910/DVN/YHUB8D/ZXCCRM","filename":"RUF_calibrationcurve_final.ods","contentType":"application/vnd.oasis.opendocument.spreadsheet","filesize":19086,"description":"Rufomycin calibration curve to determine the level of contamination in the biological assay sample of rufomyazine that was recovered","storageIdentifier":"s3://dvn-cloud:15e05c26fc8-f071755f69b7","rootDataFileId":-1,"md5":"e5dd77304341c4f922c01a6f488a3a6b","checksum":{"type":"MD5","value":"e5dd77304341c4f922c01a6f488a3a6b"}}},{"description":"1H file for contaminated Rufomyazine from biological sample","label":"Rufomyazine_contaiminated_CD3OD_900.zip","restricted":false,"directoryLabel":"Rufomyazine_contaminatedsample_CD3OD_900","version":1,"datasetVersionId":128158,"dataFile":{"id":3047741,"persistentId":"doi:10.7910/DVN/YHUB8D/0KJFQ1","pidURL":"https://doi.org/10.7910/DVN/YHUB8D/0KJFQ1","filename":"Rufomyazine_contaiminated_CD3OD_900.zip","contentType":"application/zip","filesize":603414,"description":"1H file for contaminated Rufomyazine from biological sample","storageIdentifier":"s3://dvn-cloud:15df79ba499-aab98ef77cd3","rootDataFileId":-1,"md5":"da756548c68afdac1a3f79311b7a1f51","checksum":{"type":"MD5","value":"da756548c68afdac1a3f79311b7a1f51"}}},{"description":"File contains all NMR obtained in CD3OD at 900 MHz for Rufomyazine (compound 6) - 1H, 13C, HSQC, COSY, HMBC, and annotated spectra for 1H and 13H ","label":"Rufomyazine_isolated_NMR_CD3OD_900.zip","restricted":false,"directoryLabel":"Rufomyazine_isolated_NMR_CD3OD_900","version":1,"datasetVersionId":128158,"dataFile":{"id":3047319,"persistentId":"doi:10.7910/DVN/YHUB8D/CZFDXJ","pidURL":"https://doi.org/10.7910/DVN/YHUB8D/CZFDXJ","filename":"Rufomyazine_isolated_NMR_CD3OD_900.zip","contentType":"application/zip","filesize":12459759,"description":"File contains all NMR obtained in CD3OD at 900 MHz for Rufomyazine (compound 6) - 1H, 13C, HSQC, COSY, HMBC, and annotated spectra for 1H and 13H ","storageIdentifier":"s3://dvn-cloud:15df1920d8b-57201daece5f","rootDataFileId":-1,"md5":"38236831d4ddbdf69b18099b4a873940","checksum":{"type":"MD5","value":"38236831d4ddbdf69b18099b4a873940"}}},{"description":".mol structure file of rufomyzaine","label":"rufomyazine.mol","restricted":false,"version":2,"datasetVersionId":128158,"dataFile":{"id":3047327,"persistentId":"doi:10.7910/DVN/YHUB8D/PARWCX","pidURL":"https://doi.org/10.7910/DVN/YHUB8D/PARWCX","filename":"rufomyazine.mol","contentType":"text/plain","filesize":2062,"description":".mol structure file of rufomyzaine","storageIdentifier":"s3://dvn-cloud:15df20257b4-cbcc1e43a76b","rootDataFileId":-1,"md5":"04e15da19300fe3017d845adae56786b","checksum":{"type":"MD5","value":"04e15da19300fe3017d845adae56786b"}}},{"description":"Contains simulated spectra of Rufomyazine in CD3OD at 900 MHz (.mms, .pms, .jdx)","label":"Rufomyazine_simulated.zip","restricted":false,"directoryLabel":"263_Rufomyazine_Sim","version":1,"datasetVersionId":128158,"dataFile":{"id":3047326,"persistentId":"doi:10.7910/DVN/YHUB8D/AIU8JQ","pidURL":"https://doi.org/10.7910/DVN/YHUB8D/AIU8JQ","filename":"Rufomyazine_simulated.zip","contentType":"application/zip","filesize":33551,"description":"Contains simulated spectra of Rufomyazine in CD3OD at 900 MHz (.mms, .pms, .jdx)","storageIdentifier":"s3://dvn-cloud:15df1fed18b-b518efb98d30","rootDataFileId":-1,"md5":"19eaaa11ecb1d70ea10147f584532c65","checksum":{"type":"MD5","value":"19eaaa11ecb1d70ea10147f584532c65"}}},{"description":"NMR files for synthetically produced Rufomyazine (1H, 13C, COSY)","label":"Rufomyazine_synthetic_NMR_CD3OD_900.zip","restricted":false,"directoryLabel":"Rufomyazine_synthetic_NMR_CD30D_900","version":1,"datasetVersionId":128158,"dataFile":{"id":3047731,"persistentId":"doi:10.7910/DVN/YHUB8D/YN7OZ0","pidURL":"https://doi.org/10.7910/DVN/YHUB8D/YN7OZ0","filename":"Rufomyazine_synthetic_NMR_CD3OD_900.zip","contentType":"application/zip","filesize":3508279,"description":"NMR files for synthetically produced Rufomyazine (1H, 13C, COSY)","storageIdentifier":"s3://dvn-cloud:15df70f5306-2a809d81fd9b","rootDataFileId":-1,"md5":"fbdb93cef3d2d0ba033888b579a235f9","checksum":{"type":"MD5","value":"fbdb93cef3d2d0ba033888b579a235f9"}}}]}}}